Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thailand Plans To Produce Own Generics Of Major Drugs

This article was originally published in PharmAsia News

Executive Summary

Thailand's Government Pharmaceutical Organization is building a $22.2 million plant to manufacture its own versions of major drugs it feels are too expensive. The plant is expected to be completed within six months and able to produce its first drugs early next year, at a rate of three billion tablets a year. The GPO currently imports generics from other countries to replace branded drugs it has declared subject to compulsory license. With its own plant, the agency hopes to save money on even the imports and speed patient access to the medicines. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067904

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel